Table 1 Summary of the included case reports of endobronchial melanoma
From: Primary endobronchial melanoma: a case report and clinical management indications
Author | Year | Sex | Age | Involved Bronchus | Diagnosis | Histology | Treatment | Status | Survival time or follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|
Nigi A [18] | 2021 | M | 71 | LB | Transbronchial biopsy | HMB45, Melan-A, S100 | Pembrolizumab | DOD | 3 |
Bernal L [19] | 2021 | F | 59 | IB | Bronchoscopy | S100, HMB45 | Pembrolizumab | NED | 24 |
Wilson RW [5] | 1997 | M | 71 | LLL | Lobe | S100, HMB45 | NA | NED | 108 |
Wilson RW [5] | 1997 | M | 45 | LUL | Wedge | S100, HMB45 | NA | AWD | 4 |
Wilson RW [5] | 1997 | F | 55 | RUL | Lobe | S100, HMB45 | NA | DOD | 18 |
Wilson RW [5] | 1997 | M | 52 | LUL | Lobe | S100, HMB45 | NA | DOD | 32 |
Wilson RW [5] | 1997 | M | 64 | LUL | Lobe | S100, HMB45 | NA | DOD | 4 |
Wilson RW [5] | 1997 | M | 48 | LUL | Lobe | S100, HMB45 | NA | DOD | 14 |
Wilson RW [5] | 1997 | M | 50 | LUL | Lobe | S100, HMB45 | NA | AWD | 30 |
Hwang K-B [20] | 2015 | M | 82 | RLL | Bronchoscopy | S100, HMB45 | No treatment | NA | NA |
Yamamoto Y [21] | 2017 | F | 61 | S10 | Wedge | S100, HMB45 | DTIC, Anti-PD-1 | DOD | 15 |
Kyriakopoulos C [22] | 2017 | F | 56 | RUL | Bronchoscopy | MART-1, S100, HMB45 | DTIC, IFNa2a, ipilimumab | DOD | 5 |
Kim BC [23] | 2023 | M | 62 | Lingular bronchus | Bronchoscopy | S100, HMB45, BRAF V600E | lobe and lymphadenectomy, pembrolizumab, dabrafenib + trametinib | AWD | 9 |
Mada PK [24] | 2023 | M | 63 | RUL | Bronchoscopy | SOX10 | Nivolumab + Ipilimumab | DOD | 2 |
Yabuki H [25] | 2018 | M | 74 | RB | Bronchoscopy | S100, HMB45 | No treatment | NED | 7 |
Taboada CF [12] | 1972 | M | 40 | LB | Bronchoscopy | Melanin pigment | Pneumonectomy | NED | 36 |
Zhang X [26] | 2015 | M | 60 | LLB | Bronchoscopy | S100, HMB45, alfa-smooth muscle actin | Pneumonectomy and adjuvant chemotherapy | NED | 18 |
Azuma Y [27] | 2018 | F | 47 | LB | Semi-rigid bronchoscopy | Pigmented mass | Nivolumab + Ipilimumab, Paclitaxel | DOD | 3 |
dos Santos CL [28] | 2013 | F | 62 | LUL | Bronchoscopy | NA | RT, Dacarbazine | AWD | 12 |
Adebonojo SA [29] | 1979 | F | 55 | RUL | Bronchoscopy | Melanin pigment | Adjuvant Melphalan | NA | NA |
Bagwell SP [30] | 1989 | M | 62 | LUL | Bronchoscopy | NA | Lobe | DOD | 2 |
Filosso PL [31] | 2003 | M | 55 | IB | Bronchoscopy | S100, HMB45 | Pneumonectomy | NED | 14 |
Farrell DJ [11] | 1996 | F | 66 | LLL | Bronchoscopy | NA | Lobe | NED | 54 |
Dountsis A [32] | 2003 | F | 41 | RUL | Bronchoscopy | S100, HMB45 | Pneumonectomy | NED | 18 |
Barzò P [16] | 1995 | F | 48 | LUL | Bronchoscopy | NA | Pneumonectomy | NED | 72 |
Barzò P [16] | 1995 | F | 81 | LB | Bronchoscopy | NA | Follow-up | DOD | 5 |
Salm R [33] | 1963 | M | 45 | LLL | Autopsy | NA | Pneumonectomy | DOD | 7 |